Marco Mernberger

Robert Koch Str. 6
Marburg An Der Lahn, HE 35037, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

Journal: The EMBO journal

Published: February 19, 2026

mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.

mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.

Journal: Cell death & disease

Published: June 25, 2025

Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers.

Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers.

Journal: Cancer letters

Published: October 21, 2024

Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

Journal: International journal of cancer

Published: May 10, 2024

Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.

Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.

Journal: Nature genetics

Published: March 17, 2024

DARPin-induced reactivation of p53 in HPV-positive cells.

DARPin-induced reactivation of p53 in HPV-positive cells.

Journal: Nature structural & molecular biology

Published: February 01, 2024

Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signaling.

Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signaling.

Journal: Radiation oncology (London, England)

Published: January 03, 2024

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.

Journal: Molecular cancer

Published: March 29, 2022

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.

Journal: Cell death and differentiation

Published: February 07, 2022

Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors.

Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors.

Journal: Cancers

Published: August 27, 2021

p53 partial loss-of-function mutations sensitize to chemotherapy.

p53 partial loss-of-function mutations sensitize to chemotherapy.

Journal: Oncogene

Published: June 09, 2021

Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging.

Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging.

Journal: Cancer research

Published: June 12, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026